Neuland Laboratories Ltd.

NSE: NEULANDLAB | BSE: 524558 | ISIN: INE794A01010 | Industry: Pharmaceuticals
| Expensive Performer
12433.0000 -180.00 (-1.43%)
NSE Apr 02, 2026 15:31 PM
Volume: 21,985
 

logo
Neuland Laboratories Ltd.
04 Nov 2020, 12:00AM
12433.00
-1.43%
BP Wealth
Neuland lab (NLL) has posted revenue of INR2,414mn with a 29.6% YoY increase, which was 12% below our estimate of INR 2,160mn. The revenue growth was mainly driven by strong traction in the CMS (54.6% YoY growth) segment, led by 33 molecules (Development + Commercialize) along with...
Number of FII/FPI investors increased from 248 to 257 in Dec 2025 qtr.
More from Neuland Laboratories Ltd.
Recommended